Barclays analyst Matt Miksic maintains Intuitive Surgical (NASDAQ:ISRG) with a Overweight and raises the price target from $430 to $490.
Barclays Maintains Overweight on Intuitive Surgical, Raises Price Target to $490
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.